Trevor Collingwood

Chief Technology Officer at Acrigen Biosciences

Trevor is a leading expert in gene editing technology having worked with pioneers in the field link Sangamo and CRISPR Therapeutics. He is responsible for developing Acrigen’s Precision Gene Editing technology and applying it to therapeutic targets.

Location

San Francisco, United States

Links


Org chart


Teams


Offices

This person is not in any offices


Acrigen Biosciences

Acrigen Biosciences is an early-stage life science gene-editing company based in Berkeley, California. They are building a pipeline of therapies to treat genetic disorders using their proprietary precision gene-editing technology.


Industries

Employees

1-10

Links